title: The effects of cytokines, antithyroidal drugs and glucocorticoids on phagocytosis by thyroid cells.
abstract: The present study was undertaken to examine whether thyrocytes possess phagocytic activity and whether the phagocytic activity is influenced by cytokines, such as interleukin 1, 2 (IL 1, IL 2) and interferon-alpha, -beta, and -gamma (IFN-alpha, beta, and gamma), and drugs, such as methimazole and dexamethasone. Thyroid glands were obtained from patients with Graves' disease. Thyrocytes were prepared by collagenase digestion. Thyrocytes were pre-incubated in the presence or absence of cytokines and drugs at 37 degrees C for 20 h and were further incubated with fluoresceinated latex beads at 37 degrees C for 60 min. The number of phagocytic thyrocytes was determined by FACS IV. Phagocytosis of latex beads was indeed seen within thyrocytes and gradually increased in a time-dependent manner. The rate of phagocytosis in thyrocytes was extremely slow as compared with that in macrophages. Phagocytic activity was detected in thyrocytes from patients with Graves' disease and from normal thyroid tissue adjacent to thyroid cancer. Phagocytosis was inhibited by IL 1, but was enhanced by IL 2. Although the enhanced phagocytosis with IFN-beta was consistently seen, little effect was detected with IFN-alpha and -gamma. Both methimazole and dexamethasone markedly inhibited phagocytosis. These results indicated that thyrocytes had phagocytic properties and that their phagocytic activity was modulated by cytokines, antithyroidal drugs and dexamethasone.
authors: First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
authors: M
authors: M
authors: Matsunaga
authors: K
authors: K
authors: Eguchi
authors: T
authors: T
authors: Fukuda
authors: H
authors: H
authors: Tezuka
authors: Y
authors: Y
authors: Ueki
authors: Y
authors: Y
authors: Kawabe
authors: C
authors: C
authors: Shimomura
authors: T
authors: T
authors: Otsubo
authors: N
authors: N
authors: Ishikawa
authors: K
authors: K
authors: Ito
mesh_terms: D013956:Antithyroid Agents / Q000494:pharmacology*; D001685:Biological Factors / Q000494:pharmacology*; D016207:Cytokines; D003907:Dexamethasone / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006111:Graves Disease / Q000276:immunology; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D008713:Methimazole / Q000494:pharmacology; D008856:Microscopy, Fluorescence; D010587:Phagocytosis / Q000187:drug effects*; D013961:Thyroid Gland / Q000166:cytology / Q000276:immunology*
chemical_list: D013956:Antithyroid Agents; D001685:Biological Factors; D016207:Cytokines; D005938:Glucocorticoids; D007370:Interferon Type I; D007375:Interleukin-1; D007376:Interleukin-2; D008713:Methimazole; D003907:Dexamethasone; D007371:Interferon-gamma